Cell Reports
Volume 20, Issue 2, 11 July 2017, Pages 439-450
Journal home page for Cell Reports

Article
Viral Activation of Heparanase Drives Pathogenesis of Herpes Simplex Virus-1

https://doi.org/10.1016/j.celrep.2017.06.041Get rights and content
Under a Creative Commons license
open access

Highlights

  • HPSE, activated virally or non-virally, triggers pro-inflammatory disease conditions

  • Active HPSE, rather than the proenzyme, can generate disease-like conditions

  • HPSE upregulation requires HSV-1 infected cell protein 34.5

  • Pharmacological inhibition of HPSE activity thwarts viral pathogenesis

Summary

Herpes simplex virus-1 (HSV-1) causes lifelong recurrent pathologies without a cure. How infection by HSV-1 triggers disease processes, especially in the immune-privileged avascular human cornea, remains a major unresolved puzzle. It has been speculated that a cornea-resident molecule must tip the balance in favor of pro-inflammatory and pro-angiogenic conditions observed with herpetic, as well as non-herpetic, ailments of the cornea. Here, we demonstrate that heparanase (HPSE), a host enzyme, is the molecular trigger for multiple pathologies associated with HSV-1 infection. In human corneal epithelial cells, HSV-1 infection upregulates HPSE in a manner dependent on HSV-1 infected cell protein 34.5. HPSE then relocates to the nucleus to regulate cytokine production, inhibits wound closure, enhances viral spread, and thus generates a toxic local environment. Overall, our findings implicate activated HPSE as a driver of viral pathogenesis and call for further attention to this host protein in infection and other inflammatory disorders.

Keywords

cornea
cytokines
heparan sulfate
heparanase
herpes simplex virus
inflammation
interferon
ophthalmology
transcription factors
wound healing

Cited by (0)

4

Lead Contact